R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation-Reference-Cited by-同舟云学术

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Published:2006-08-31 Issue:3 Volume:319 Page:998-1008
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Braselmann Sylvia,Taylor Vanessa,Zhao Haoran,Wang Su,Sylvain Catherine,Baluom Muhammad,Qu Kunbin,Herlaar Ellen,Lau Angela,Young Chi,Wong Brian R.,Lovell Scott,Sun Thomas,Park Gary,Argade Ankush,Jurcevic Stipo,Pine Polly,Singh Rajinder,Grossbard Elliott B.,Payan Donald G.,Masuda Esteban S.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Priming of neutrophils with tumor necrosis factor-α measured as Fcγ receptor-mediated respiratory burst correlates with increased complement receptor 3 membrane density

2. Src and Syk kinases: key regulators of phagocytic cell activation

3. A Novel Spleen Tyrosine Kinase Inhibitor Blocks c-Jun N-Terminal Kinase-Mediated Gene Expression in Synoviocytes

4. Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin alpha IIb beta 3.

Cited by 443 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. R406 reduces lipopolysaccharide-induced neutrophil activation;Cellular Immunology;2024-09

2. Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors;European Journal of Medicinal Chemistry;2024-09

3. Polygenic prediction of human longevity on the supposition of pervasive pleiotropy;Scientific Reports;2024-08-28

4. The Syk Inhibitor Entospletinib Abolishes Dermal–Epidermal Separation in a Fully Human Ex Vivo Model of Bullous Pemphigoid;Journal of Investigative Dermatology;2024-08

5. Development of SYK NanoBRET cellular target engagement assays for gain–of–function variants;Frontiers in Chemical Biology;2024-07-29